These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 14719052)
1. Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib. Nam DH; Park K; Park C; Im YH; Kim MH; Lee S; Hong SC; Shin HJ; Kim JH; Eoh W; McDonnell TJ Oncol Rep; 2004 Feb; 11(2):263-8. PubMed ID: 14719052 [TBL] [Abstract][Full Text] [Related]
2. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells. Suh YJ; Chada S; McKenzie T; Liu Y; Swisher SG; Lucci A; Hunt KK Surgery; 2005 Sep; 138(3):422-30. PubMed ID: 16213894 [TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effects of celecoxib combined with octreotide on growth of multidrug resistant human gastric cancer cell line SGC7901/ADR]. Zheng WB; Wang CH; Qiang O; Tang CW Ai Zheng; 2004 Dec; 23(12):1628-32. PubMed ID: 15601550 [TBL] [Abstract][Full Text] [Related]
5. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. Liu X; Yue P; Zhou Z; Khuri FR; Sun SY J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759 [TBL] [Abstract][Full Text] [Related]
6. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt. Liu B; Shi ZL; Feng J; Tao HM Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766 [TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS; Liu DS; Dai CW; Li RJ Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer. Basu GD; Pathangey LB; Tinder TL; Lagioia M; Gendler SJ; Mukherjee P Mol Cancer Res; 2004 Nov; 2(11):632-42. PubMed ID: 15561779 [TBL] [Abstract][Full Text] [Related]
9. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455 [TBL] [Abstract][Full Text] [Related]
10. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats. Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774 [TBL] [Abstract][Full Text] [Related]
11. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230 [TBL] [Abstract][Full Text] [Related]
12. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence. Narayanan BA; Reddy BS; Bosland MC; Nargi D; Horton L; Randolph C; Narayanan NK Clin Cancer Res; 2007 Oct; 13(19):5965-73. PubMed ID: 17908994 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis. Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239 [TBL] [Abstract][Full Text] [Related]
14. The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice. Klenke FM; Gebhard MM; Ewerbeck V; Abdollahi A; Huber PE; Sckell A BMC Cancer; 2006 Jan; 6():9. PubMed ID: 16409625 [TBL] [Abstract][Full Text] [Related]
15. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels. Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415 [TBL] [Abstract][Full Text] [Related]
16. Celecoxib after the onset of reperfusion reduces apoptosis in the amygdala. Kaloustian S; Wann BP; Bah TM; Falcao S; Dufort AM; Ryvlin P; Godbout R; Rousseau G Apoptosis; 2007 Nov; 12(11):1945-51. PubMed ID: 17828456 [TBL] [Abstract][Full Text] [Related]
17. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of cyclooxygenase (COX)-2 in DMBA-induced hamster cheek pouch carcinogenesis and chemopreventive effect of a selective COX-2 inhibitor celecoxib. Nishimura N; Urade M; Hashitani S; Noguchi K; Manno Y; Takaoka K; Sakurai K J Oral Pathol Med; 2004 Nov; 33(10):614-21. PubMed ID: 15482328 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells. Qin J; Yuan J; Li L; Liu H; Qin R; Qin W; Chen B; Wang H; Wu K Biomed Pharmacother; 2009 Mar; 63(3):241-8. PubMed ID: 18617357 [TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. Guo JY; Li CY; Ruan YP; Sun M; Qi XL; Zhao BS; Luo F Eur J Pharmacol; 2009 Jun; 612(1-3):54-60. PubMed ID: 19356723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]